Healthcare -
Biotechnology - NASDAQ - US
$ 2.74
12.8 %
$ 134 M
Market Cap
-1.27
P/E
CABA - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities CABA - Cabaletta Bio, Inc.
188 M
LAST VALUE
95.88%
2 YEAR CAGR
37.86%
5 YEAR CAGR
0.00%
10 YEAR CAGR